Brief: Aytu Biopharma announces issuance of its first patent for Ar101/Enzastaurin
16/08/2022 13:21
Aug 16 (Reuters) - Aytu Biopharma Inc AYTU.O :
* AYTU BIOPHARMA ANNOUNCES ISSUANCE OF ITS FIRST PATENT FOR
AR101/ENZASTAURIN
Further company coverage: AYTU.O
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations